H. Lee Moffitt Cancer Center and Research Institute
2 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a Phase 1/2 single-arm trial still recruiting with no posted results; early-phase design and lack of comparative data limit evidential strength.
Phase 1 pilot study of a novel dendritic cell vaccine combined with elacestrant in metastatic breast cancer; designed to assess feasibility and safety, not efficacy, with no results yet reported in this registry record.